US Stock MarketDetailed Quotes
CPHI China Pharma
- 0.2005
- +0.0005+0.25%
Trading Nov 29 09:59 ET
3.86MMarket Cap-802P/E (TTM)
0.2040High0.2005Low21.93KVolume0.2040Open0.2000Pre Close4.42KTurnover0.24%Turnover RatioLossP/E (Static)19.25MShares0.720052wk High0.59P/B1.87MFloat Cap0.170052wk Low--Dividend TTM9.34MShs Float2044.2703Historical High--Div YieldTTM1.75%Amplitude0.1700Historical Low0.2010Avg Price1Lot Size
China Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 359.69%1.01M | 35.16%-216.44K | -66.95%-1.47M | -63.92%-409.55K | 395.08%584.59K | 148.60%219.12K | -149.38%-333.82K | -217.58%-879.44K | -491.19%-249.84K | -159.16%-198.11K |
| Net income from continuing operations | 1.67%-777.6K | 33.25%-593.03K | 53.77%-475.98K | -16.87%-3.97M | -28.90%-1.26M | 4.34%-790.77K | -7.72%-888.39K | -34.17%-1.03M | -18.58%-3.4M | 18.88%-980.72K |
| Depreciation and amortization | 2.82%683.09K | 1.70%694.84K | -4.72%679.88K | -12.54%2.7M | -10.03%639.43K | -31.96%664.34K | -2.46%683.21K | 1.91%713.56K | 15.24%3.09M | 1.37%710.72K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --250K | ---- |
| Change In working capital | 161.97%1.1M | -203.67%-346.55K | -192.54%-1.66M | 1,595.97%878.34K | 416.62%1.14M | 164.42%419.4K | -115.47%-114.12K | -122.19%-568.15K | 73.44%51.79K | -71.31%220.9K |
| -Change in receivables | -8.67%-229.31K | 181.67%89.86K | -268.25%-434.31K | 68.80%-170.19K | 72.75%-107.29K | -578.17%-211.01K | -170.95%-110.03K | 193.59%258.13K | 11.10%-545.53K | -59.19%-393.66K |
| -Change in inventory | -11.48%515.33K | -165.89%-238.36K | -23.44%-552.69K | -31.90%689.1K | -24.59%192.9K | 533.35%582.19K | -46.72%361.76K | -311.81%-447.75K | 25.30%1.01M | 3.80%255.82K |
| -Change in prepaid assets | -555.66%-10.78K | 630.56%182.41K | 814.65%67.28K | -2,179.91%-484.68K | -880.79%-439.24K | 97.15%-1.64K | -310.60%-34.38K | -212.15%-9.41K | 252.92%23.3K | -86.75%56.26K |
| -Change in payables and accrued expense | 613.49%704.85K | 8.56%-313.49K | -19.04%-350.35K | 511.24%504.46K | 101.27%1.04M | 130.47%98.79K | -508.45%-342.85K | -434.48%-294.31K | 136.00%82.53K | 74.41%518.12K |
| -Change in other working capital | 342.39%118.59K | -688.77%-66.98K | -423.99%-392.02K | 165.27%339.66K | 309.63%452.02K | 52.83%-48.92K | 120.15%11.38K | 48.26%-74.81K | -406.60%-520.41K | -526.67%-215.63K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 359.69%1.01M | 35.16%-216.44K | -66.95%-1.47M | -63.92%-409.55K | 395.08%584.59K | 148.60%219.12K | -149.38%-333.82K | -217.58%-879.44K | -491.19%-249.84K | -159.16%-198.11K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 73.29%-67.46K | 102.57%4.5K | 4,123.29%55.96K | 8.24%-401.96K | 486.45%27.27K | 39.29%-252.55K | -1,066.90%-175.29K | -1.39K | 49.49%-438.06K | -103.03%-7.06K |
| Net PPE purchase and sale | 73.29%-67.46K | 102.57%4.5K | 4,123.29%55.96K | 8.24%-401.96K | 486.45%27.27K | 39.29%-252.55K | -1,066.90%-175.29K | ---1.39K | 49.49%-438.06K | -103.03%-7.06K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 73.29%-67.46K | 102.57%4.5K | 4,123.29%55.96K | 8.24%-401.96K | 486.45%27.27K | 39.29%-252.55K | -1,066.90%-175.29K | ---1.39K | 49.49%-438.06K | -103.03%-7.06K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -1,778.13%-476.4K | 100.11%934 | 287.92%518.24K | -138.50%-1.77M | -114.55%-672.06K | 106.68%28.39K | -255.20%-850.56K | -89.98%-275.78K | 636.61%4.6M | 45,928.53%4.62M |
| Net issuance payments of debt | -134.72%-476.4K | 100.15%934 | 287.92%518.24K | -138.50%-1.77M | -114.55%-672.06K | 52.26%-202.97K | -212.98%-619.2K | -89.98%-275.78K | 636.61%4.6M | 45,928.53%4.62M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -1,778.13%-476.4K | 100.11%934 | 287.92%518.24K | -138.50%-1.77M | -114.55%-672.06K | 106.68%28.39K | -255.20%-850.56K | -89.98%-275.78K | 636.61%4.6M | 45,928.53%4.62M |
| Net cash flow | ||||||||||
| Beginning cash position | -59.83%901.91K | -68.59%1.17M | -58.22%2.03M | 407.39%4.86M | 354.70%2.09M | 27.93%2.24M | 594.97%3.71M | 407.39%4.86M | -19.18%957.65K | 32.38%458.83K |
| Current changes in cash | 9,298.63%463.43K | 84.48%-211K | 22.70%-894.01K | -166.03%-2.58M | -101.36%-60.2K | 99.61%-5.04K | -212.46%-1.36M | -174.03%-1.16M | 1,470.00%3.91M | 692.10%4.41M |
| Effect of exchange rate changes | 102.95%4.53K | 50.96%-54.04K | 150.76%30.99K | -2,833.67%-247.57K | 126.58%3.88K | -3,654.30%-153.63K | -1,077.20%-110.18K | 1,283.72%12.36K | -114.51%-8.44K | -127.16%-14.58K |
| End cash Position | -34.34%1.37M | -59.83%901.91K | -68.59%1.17M | -58.22%2.03M | -58.22%2.03M | 354.70%2.09M | 27.93%2.24M | 594.97%3.71M | 407.39%4.86M | 407.39%4.86M |
| Free cash flow | 3,092.48%1M | 57.49%-216.44K | -66.69%-1.47M | -17.97%-811.51K | 398.22%611.86K | 96.14%-33.43K | -177.02%-509.11K | -218.09%-880.83K | 24.37%-687.89K | -136.16%-205.17K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data